https://www.selleckchem.com/pr....oducts/Verteporfin(V
A to increase TTP may be a novel strategy for high fructose diet-associated podocyte injury and proteinuria.Etoposide, a DNA damage-inducing agent, is widely used to treat neuroblastoma. Etoposide binds to and inhibits topoisomerase II, thereby inducing the DNA damage response. However, the underlying mechanism of etoposide resistance in neuroblastoma remains unclear. The results of the present study revealed that etoposide upregulated growth hormone receptor (GHR) expression levels in etoposide-resistant neuroblastoma cel